Leucovorin Calcium Market

Global Leucovorin Calcium Market Size, Share and Trend Analysis Report, By Type (Tablets and Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025453 | Category : Pharmaceuticals | Delivery Format: /

The global leucovorin calcium market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to fuel the market includes the rise in the prevalence of cancer, which increases the need for leucovorin calcium, as it is an effective drug used during chemotherapy. Moreover, the rise in the prevalence of cancer in most of the developed and developing countries is another factor that is anticipated to boost the growth of the market during the forecast period. In 2020, around 19.3 million new cancer cases were recorded globally, which is projected to drive the demand for cancer treatment, which in turn is anticipated to increase the need for leucovorin calcium globally. 

Leucovorin calcium is an active metabolite of folic acid. Leucovorin calcium aids in providing a counteracting effect on the toxic medications, thereby protecting the patient while enabling the antitumor activity of the folate antagonist. Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer may be used to treat folate deficiency that results in anemia, and methanol poisoning. Moreover, Leucovorin calcium also elevates the effect of fluorouracil as well as its derivatives by stabilizing the binding of the drug metabolites to a target enzyme. This aids in prolonging the drug activity. Leucovorin calcium can potentially enhance the effect of chemotherapy drugs and works as a chemo-protectant. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Teva Pharmaceutical Industries Ltd., Mylan N.V., and Hikma Pharmaceuticals plc, among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Leucovorin Calcium Market Report by Segment

By Type 

Tablets 

Injection

By Distribution Channel 

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Leucovorin Calcium Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World